This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
6 Mar 2012

Medicyte & PRIMACYT Receive Grant to Develop Human Liver Cells for Cell-based Therapies

Medicyte and PRIMACYT have received a grant from the BMBF to develop culturing methods of human hepatocytes for use in cell-based therapies.

Medicyte and PRIMACYT have received a 300k Euro grant from the BMBF to develop culturing methods of human hepatocytes for use in cell-based therapies.

 

Cell-based therapies and the development of transplantable bioartificial livers to treat severe liver diseases still fail due to the limited availability of appropriate cells in large numbers and clinical quality. These failures are often related to the complex and difficult culturing of liver cells.

 

Medicyte’s upcyte? technology enables the expansion of human primary liver cells to large amounts and with consistent quality. Upcyte? hepatocytes are functionally equivalent to human primary liver cells and therefore suitable for use in cell-based bioartificial liver systems.

Related News